T. Rowe Price Investment Management »

Apogee Therapeutics shares owned by T. Rowe Price Investment Management

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by T. Rowe Price Investment Management from 13F filings

Historical chart of T. Rowe Price Investment Management investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by T. Rowe Price Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $58k 1.4k 40.25
2025-06-30 $21k 464 45.26

More positions owned by T. Rowe Price Investment Management

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
PTC Comm Stk (PTC)
Becton Dickinson & Co Comm Stk (BDX)
Meta Platforms Comm Stk (META)
Yum Brands Comm Stk (YUM)
Abbott Labs Comm Stk (ABT)
Alphabet Comm Stk (GOOGL)
Centerpoint Energy Comm Stk (CNP)
Revvity Comm Stk (RVTY)
Nisource Comm Stk (NI)
Advanced Micro Devices Comm Stk (AMD)
Ameren Corp Comm Stk (AEE)

View all positions for T. Rowe Price Investment Management

Top funds holding Apogee Therapeutics

VR Adviser
FMR
Wellington Management Company
Rtw Investments
BlackRock
Vanguard Group
Driehaus Capital Management
Fairmount Funds Management
State Street Corporation
Paradigm Biocapital Advisors
Braidwell
Alliancebernstein
Perceptive Advisors
Citadel Advisors
Affinity Asset Advisors

View all funds holding Apogee Therapeutics